Kazakhstan vs Palau: New cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
Palau
100.0%
in 2024
Kazakhstan rank
1st
Palau rank
1st
New cases tested for RR-/MDR-TB over time
- Kazakhstan
- Palau
How they compare
Kazakhstan currently reports 100.0% against 100.0% in Palau, a difference of 0.0%.
The two have swapped places 3 times across 16 shared years of data; in 2007 it was Kazakhstan ahead.
Kazakhstan ranks 1st and Palau ranks 1st of 192 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Palau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 80.0% | 20.0% | Kazakhstan |
| 2010s | 97.1% | 94.4% | 2.7% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Kazakhstan or Palau?
- Kazakhstan, at 100.0% against 100.0% in Palau as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Kazakhstan and Palau?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Palau?
- 16 years are reported by both, from 2007 to 2024.
- How do Kazakhstan and Palau rank globally for new cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and Palau ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.